Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Many households succeed with zero based budgeting because it ties every expense to a purpose, preventing ambiguity and overspending.
25,253 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Tesla stands out as a founder led tech titan in a sea of transitions. This guide explains why elon musk's tesla remai...
When the carradine family breaks hollywood, they show how openness can shape finances and future planning. This artic...
In February, Newmont Mining surged as gold prices strengthened and earnings topped expectations. This piece breaks do...
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
A proposed state ban on institutional buyers could change how Californians get loans for homes and how lenders price ...
As AI systems evolve, a watchdog warns 'rogue deployment' risk at top labs. This deep dive explains what rogue deploy...
Oil prices rose and energy stocks jumped after the tensions since iran began. This guide breaks down whether it’s sti...
Walmart’s John Furner rose from a garden center associate to CEO of Walmart U.S., guiding the retailer through a tech...
Confused by Rocket Lab's stock moves? This guide explains the core forces behind RKLB, how the business is evolving, ...
A veteran market commentator shines a light on a legacy chipmaker as a serious AI play. This analysis weighs the case...
A storied dividend king trades at a discount as Wall Street shifts away. Here’s why patient investors are doubling do...